X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (34) 34
oncology (27) 27
humans (25) 25
radiotherapy (25) 25
cancer (22) 22
male (21) 21
middle aged (16) 16
aged (14) 14
radiology, nuclear medicine & medical imaging (14) 14
female (13) 13
adult (12) 12
life sciences (12) 12
prostate cancer (12) 12
radiation-therapy (11) 11
care and treatment (10) 10
radiation (10) 10
retrospective studies (10) 10
surgery (10) 10
bladder cancer (9) 9
chemotherapy (9) 9
sarcoma (9) 9
urology & nephrology (9) 9
analysis (8) 8
metastasis (8) 8
research (8) 8
survival (8) 8
tumors (8) 8
aged, 80 and over (7) 7
diagnosis (7) 7
radiation therapy (7) 7
treatment outcome (7) 7
[sdv.can]life sciences [q-bio]/cancer (6) 6
hematology, oncology and palliative medicine (6) 6
management (6) 6
medical prognosis (6) 6
oncology, experimental (6) 6
patients (6) 6
postoperative radiotherapy (6) 6
adenocarcinoma (5) 5
cystectomy (5) 5
follow-up (5) 5
locoregional failure (5) 5
prognosis (5) 5
prognostic-factors (5) 5
radical cystectomy (5) 5
radical prostatectomy (5) 5
randomized-trial (5) 5
recurrence (5) 5
bioengineering (4) 4
clinical trials (4) 4
extremity (4) 4
metastases (4) 4
mortality (4) 4
radiotherapy, adjuvant (4) 4
urothelial carcinoma (4) 4
usage (4) 4
[ sdv.ib ] life sciences [q-bio]/bioengineering (3) 3
adjuvant radiotherapy (3) 3
androgens (3) 3
bacteria (3) 3
bladder (3) 3
bladder neoplasm (3) 3
cancer therapies (3) 3
carcinoma (3) 3
cisplatin (3) 3
combined modality therapy (3) 3
consensus (3) 3
delphi (3) 3
external validation (3) 3
failure risk stratification (3) 3
feasibility studies (3) 3
health aspects (3) 3
intensity-modulated radiotherapy (3) 3
local-control (3) 3
magnetic resonance imaging (3) 3
medicine & public health (3) 3
multimodal treatment (3) 3
neoadjuvant chemotherapy (3) 3
neoplasm recurrence, local - pathology (3) 3
neoplasm recurrence, local - radiotherapy (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
outcomes (3) 3
phase-ii (3) 3
prostate-cancer (3) 3
prostatic neoplasms - therapy (3) 3
radiology (3) 3
radiotherapy dosage (3) 3
radiotherapy planning, computer-assisted (3) 3
radiotherapy, intensity-modulated - methods (3) 3
risk (3) 3
sarcoma - pathology (3) 3
soft tissue sarcoma (3) 3
soft-tissue sarcoma (3) 3
survival analysis (3) 3
toxicity (3) 3
transitional-cell carcinoma (3) 3
treatment (3) 3
urinary bladder neoplasms - pathology (3) 3
urology (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 5080 - 5080
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2017, Volume 197, Issue 4, pp. e1361 - e1361
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 908 - 917
Journal Article
BJU international, ISSN 1464-4096, 04/2019
We previously reported results of a randomized trial comparing androgen-deprivation therapy (ADT) combined with external beam radiation therapy (EBRT) and ADT... 
Journal Article
Journal Article
BMC Medicine, ISSN 1741-7015, 04/2017, Volume 15, Issue 1, pp. 78 - 11
Background: Well-designed observational studies of individuals with rare tumors are needed to improve patient care, clinical investigations, and the education... 
Chemotherapy | Sarcoma | Outcome | Surgery | Patterns of care | Metastases | 1ST-LINE TREATMENT | PROGNOSTIC-FACTORS | GEMCITABINE | BREAST-CANCER | DOXORUBICIN PLUS IFOSFAMIDE | WEEKLY PACLITAXEL | MEDICINE, GENERAL & INTERNAL | MALIGNANT FIBROUS HISTIOCYTOMAS | RANDOMIZED PHASE-II | EUROPEAN-ORGANIZATION | Doxorubicin - therapeutic use | Practice Patterns, Physicians' - standards | Soft Tissue Neoplasms - mortality | Leiomyosarcoma - pathology | Humans | Middle Aged | Male | Treatment Outcome | Sarcoma - pathology | Sarcoma - therapy | Leiomyosarcoma - therapy | Practice Patterns, Physicians' - statistics & numerical data | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcoma - mortality | Soft Tissue Neoplasms - pathology | Survival Analysis | Aged, 80 and over | Leiomyosarcoma - mortality | Adult | Female | Aged | Soft Tissue Neoplasms - therapy | Heart | Brain | CD8 antigen | Liver | Metastasis | Cancer therapies | Data bases | Dacarbazine | Failure analysis | Classification | Bone marrow | Diagnosis | Deoxyribonucleic acid--DNA | Cadmium | Evaluation | Cut-off | Mortality | Regression analysis | Population statistics | Patients | Survival | Cyclophosphamide | Adults | Skin | Toxicity | Identification methods | Colorectal carcinoma | Medical services | Clinical trials | Population studies | Bone tumors | Congestive heart failure | Tissue | Databases | Quality | Mathematical models | Age | Correlation coefficient | Statistical analysis | Receiving | Feasibility studies | Breast cancer | Histology | Management | Statistics | Computer programs | Bone cancer | Lungs | Medical prognosis | Breast | Three dimensional models | Elderly | Prostate cancer | Tumors | Peritoneum | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, pp. e0174978 - e0174978
Objectives Radical cystectomy (RC) and pelvic lymph-node dissection (LND) is standard treatment for non-metastatic muscle-invasive urothelial bladder cancer... 
FAILURE RISK STRATIFICATION | LYMPH-NODE DISSECTION | SURVIVAL | LOCOREGIONAL FAILURE | LOCAL RECURRENCE | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | POSTOPERATIVE RADIOTHERAPY | PROSTATE-CANCER | BILHARZIAL BLADDER | RADIATION-THERAPY | Neoplasm Invasiveness | Humans | Middle Aged | Male | Combined Modality Therapy | Muscles - pathology | Urinary Bladder Neoplasms - surgery | Urinary Bladder Neoplasms - radiotherapy | Survival Analysis | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Female | Aged | Retrospective Studies | Cystectomy - methods | Usage | Care and treatment | Radiotherapy | Bladder cancer | Adenocarcinoma | Radiation | Bifurcations | Statistical methods | Metastasis | Institutions | Metastases | Computed tomography | Urinary bladder | Surgery | Classification | Aorta | Diagnosis | Dissection | Mortality | Vagina | Thorax | Survival | Abdomen | Chemotherapy | Computation | Documents | Death | Terminology | Toxicity | Cytology | Medical services | Clinical trials | Bladder | Risk | Lymph nodes | Arteries | Urology | Clinical outcomes | Guidelines | Confidence intervals | Uterus | Intestine | Bones | Age | Urine | Medical personnel | Health risks | Benchmarks | Radiation therapy | Diversion | Statistics | Cisplatin | Magnetic resonance imaging | Medical prognosis | Resonance | Tumors | Acute toxicity | Cancer | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 04/2019, Volume 103, Issue 5, pp. 1175 - 1181
Intrathoracic sarcomas (ITS) are considered rare tumors and have a dismal prognosis. We investigated outcomes and risk factors for local control (LC),... 
MEDIASTINUM | OUTCOMES | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Antimitotic agents | Sarcoma | Analysis | Oncology, Experimental | Radiation | Adjuvant treatment | Research | Radiotherapy | Antineoplastic agents | Risk factors | Cancer
Journal Article
Journal Article
Prostate, ISSN 0270-4137, 2017, Volume 77, Issue 10, pp. 1160 - 1166
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 1, pp. 78 - 86
Journal Article